Zusammenfassung
Corticosteroide werden überwiegend als Glucocorticoide zur Entzündungshemmung und Immunsuppression eingesetzt, während die Hormonsubstitution mit dem Nebennierenrindenhormon Cortisol und dem Mineralocorticoid Fludrocortison nur einen kleinen Teil der Verordnungen (3%) betrifft.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2005): Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19(2): CD005328
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R (2008) : Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 371: 205–214
Huppertz HI, Pfuller H (1997): Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol 24: 1833–1837
Kamada AK, Wiener MB, LaVallee NM, Bartoszek SM., Selner JC, Szefler SJ (1997): A pharmacokinetic comparison of two oral liquid glucocorticoid formulations. Pharmacotherapy 17: 353–356
Köbberling J (1979): Gefahren der Depotkortikoid-Therapie. Internist Welt 4: 118–122
Lanier JB, Mote MB, Clay EC (2011): Evaluation and management of orthostatic hypotension. Am Fam Physician 84: 527–536
Medici TC, Rüegsegger P (1990): Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study. Clin Pharmacol Ther 48: 455–466
Mygind N, Laursen LC, Dahl M (2000): Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy 55: 11–15
Nasser SMS, Ewan PW (2001): Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. BMJ 322: 1589–1591
Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka- Isler T, Wong JB, van der Heijde D (2014): EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73: 492–509
Strehl C, Buttgereit F (2013): Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol 380: 32–40
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U. (2014). Corticosteroide. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs- Report 2014. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43487-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-662-43487-1_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43486-4
Online ISBN: 978-3-662-43487-1
eBook Packages: Medicine (German Language)